Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 44 Neoplasm Metastasis 5 Ovarian Neoplasms 2 Neoplasms, Hormone-Dependent 2 Carcinoma, Lobular 2 Carcinoma, Ductal, Breast 2 Advanced Breast Cancer 2 Uterine Neoplasms 1 Triple Negative Breast Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Medullary cystic kidney disease 1 1 Lymphoma, Non-Hodgkin 1 Leiomyosarcoma 1 Hormone-sensitive Metastatic Breast Cancer 1 HER2-positive Breast Cancer 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Ductal 1 Breast Neoplasms, Male 1 Breast Neoplasm Malignant Female 1 Breast Diseases 1 Breast Cancer Metastatic 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Breast Neoplasm Malignant Female × Letrozole × Clear all

NCT04289805 2025-01-31

fAMHOPE

Erasme University Hospital

Phase 4 Terminated

Breast Neoplasm Malignant Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡